Biostem Technologies Inc (BSEM) 株価予測

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The firm's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. The company also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.